Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

Table of Contents

March 1, 2022; Volume 63,Issue 3

This Month in JNM

  • You have access
    This Month in JNM
    Journal of Nuclear Medicine March 1, 2022, 63 (3) 10A;

Discussions with Leaders

  • You have access
    Health Care and Nuclear Medicine in France
    Dominique Le Guludec, Johannes Czernin and Jérémie Calais
    Journal of Nuclear Medicine March 1, 2022, 63 (3) 327-330; DOI: https://doi.org/10.2967/jnumed.122.263863

The State of The Art

  • You have access
    The History of Prostate-Specific Membrane Antigen as a Theranostic Target in Prostate Cancer: The Cornerstone Role of the Prostate Cancer Foundation
    Andrea K. Miyahira and Howard R. Soule
    Journal of Nuclear Medicine March 1, 2022, 63 (3) 331-338; DOI: https://doi.org/10.2967/jnumed.121.262997

Hot Topics

  • You have access
    The Promise of Metastasis-Directed Therapy for Oligometastatic Prostate Cancer: Going Beneath the Surface with Molecular Imaging
    Philip Sutera, Ryan M. Phillips, Matthew Deek, Gokhan Ozyigit, Cem Onal and Phuoc T. Tran
    Journal of Nuclear Medicine March 1, 2022, 63 (3) 339-341; DOI: https://doi.org/10.2967/jnumed.121.263684

Continuing Education

  • You have access
    Principles of Tracer Kinetic Analysis in Oncology, Part I: Principles and Overview of Methodology
    Austin R. Pantel, Varsha Viswanath, Mark Muzi, Robert K. Doot and David A. Mankoff
    Journal of Nuclear Medicine March 1, 2022, 63 (3) 342-352; DOI: https://doi.org/10.2967/jnumed.121.263518

Focus on Molecular Imaging

  • You have access
    Latest Advances in Multimodality Imaging of Aortic Stenosis
    Evangelos Tzolos, Jacek Kwiecinski, Daniel Berman, Piotr Slomka, David E. Newby and Marc R. Dweck
    Journal of Nuclear Medicine March 1, 2022, 63 (3) 353-358; DOI: https://doi.org/10.2967/jnumed.121.262304

Oncology

  • Clinical

    • INVITED PERSPECTIVE

      • You have access
        Toward a Better Understanding of Immune Checkpoint Inhibitor Radiolabeled PET Imaging Studies
        Harm Westdorp, Sarah R. Verhoeff, Martin Gotthardt, Carla M.L. van Herpen, Michel M. van, den Heuvel, Sandra Heskamp and Erik H.J.G. Aarntzen
        Journal of Nuclear Medicine March 1, 2022, 63 (3) 359-361; DOI: https://doi.org/10.2967/jnumed.121.262622
    • Study of <sup>89</sup>Zr-Pembrolizumab PET/CT in Patients With Advanced-Stage Non–Small Cell Lung Cancer
      You have access
      Study of 89Zr-Pembrolizumab PET/CT in Patients With Advanced-Stage Non–Small Cell Lung Cancer
      Anna-Larissa N. Niemeijer, Daniela E. Oprea-Lager, Marc C. Huisman, Otto S. Hoekstra, Ronald Boellaard, Berlinda J. de Wit-van der Veen, Idris Bahce, Daniëlle J. Vugts, Guus A.M.S. van Dongen, Erik Thunnissen, Egbert F. Smit and Adrianus J. de Langen
      Journal of Nuclear Medicine March 1, 2022, 63 (3) 362-367; DOI: https://doi.org/10.2967/jnumed.121.261926
    • Functional Characterization of Adrenocortical Masses in Nononcologic Patients Using <sup>68</sup>Ga-Pentixafor
      You have access
      Functional Characterization of Adrenocortical Masses in Nononcologic Patients Using 68Ga-Pentixafor
      Jie Ding, Anli Tong, Yushi Zhang, Jin Wen, Hui Zhang, Marcus Hacker, Li Huo and Xiang Li
      Journal of Nuclear Medicine March 1, 2022, 63 (3) 368-375; DOI: https://doi.org/10.2967/jnumed.121.261964
    • A Randomized, Factorial Phase II Study to Determine the Optimal Dosing Regimen for <sup>68</sup>Ga-Satoreotide Trizoxetan as an Imaging Agent in Patients with Gastroenteropancreatic Neuroendocrine Tumors
      Open Access
      A Randomized, Factorial Phase II Study to Determine the Optimal Dosing Regimen for 68Ga-Satoreotide Trizoxetan as an Imaging Agent in Patients with Gastroenteropancreatic Neuroendocrine Tumors
      Irene Virgolini, Shadfar Bahri, Andreas Kjaer, Henning Grønbæk, Peter Iversen, Esben A. Carlsen, Mathias Loft, Ulrich Knigge, Johanna Maffey-Steffan, Christine Powell, Colin G. Miller, Thomas Rohban, Sandy McEwan and Johannes Czernin
      Journal of Nuclear Medicine March 1, 2022, 63 (3) 376-383; DOI: https://doi.org/10.2967/jnumed.121.261936
    • BRIEF COMMUNICATION

      • Value of <sup>68</sup>Ga-DOTATOC and Carbidopa-Assisted <sup>18</sup>F-DOPA PET/CT for Insulinoma Localization
        You have access
        Value of 68Ga-DOTATOC and Carbidopa-Assisted 18F-DOPA PET/CT for Insulinoma Localization
        Alessio Imperiale, Caroline Boursier, Nicolas Sahakian, Eric Ouvrard, Elodie Chevalier, Frédéric Sebag, Pietro Addeo and David Taïeb
        Journal of Nuclear Medicine March 1, 2022, 63 (3) 384-388; DOI: https://doi.org/10.2967/jnumed.121.262401
    • Quantitative Radiomics Features in Diffuse Large B-Cell Lymphoma: Does Segmentation Method Matter?
      You have access
      Quantitative Radiomics Features in Diffuse Large B-Cell Lymphoma: Does Segmentation Method Matter?
      Jakoba J. Eertink, Elisabeth A.G. Pfaehler, Sanne E. Wiegers, Tim van, de Brug, Pieternella J. Lugtenburg, Otto S. Hoekstra, Josée M. Zijlstra, Henrica C.W. de Vet and Ronald Boellaard
      Journal of Nuclear Medicine March 1, 2022, 63 (3) 389-395; DOI: https://doi.org/10.2967/jnumed.121.262117

Theranostics

  • Clinical

    • BRIEF COMMUNICATION

      • Response to Combined Peptide Receptor Radionuclide Therapy and Checkpoint Immunotherapy with Ipilimumab Plus Nivolumab in Metastatic Merkel Cell Carcinoma
        You have access
        Response to Combined Peptide Receptor Radionuclide Therapy and Checkpoint Immunotherapy with Ipilimumab Plus Nivolumab in Metastatic Merkel Cell Carcinoma
        Justin Ferdinandus, Wolfgang P. Fendler, Katharina Lueckerath, Christoph Berliner, Sabine Kurzidem, Eva Hadaschik, Joachim Klode, Lisa Zimmer, Elisabeth Livingstone, Dirk Schadendorf, Ken Herrmann, Juergen C. Becker and Selma Ugurel
        Journal of Nuclear Medicine March 1, 2022, 63 (3) 396-398; DOI: https://doi.org/10.2967/jnumed.121.262344
    • Dosimetric Quantities in Neuroendocrine Tumors over Treatment Cycles with <sup>177</sup>Lu-DOTATATE
      You have access
      Dosimetric Quantities in Neuroendocrine Tumors over Treatment Cycles with 177Lu-DOTATATE
      Daniel Roth, Johan Gustafsson, Carl Fredrik Warfvinge, Anna Sundlöv, Anna Åkesson, Jan Tennvall and Katarina Sjögreen Gleisner
      Journal of Nuclear Medicine March 1, 2022, 63 (3) 399-405; DOI: https://doi.org/10.2967/jnumed.121.262069
    • BRIEF COMMUNICATION

      • Intraarterial Administration Boosts <sup>177</sup>Lu-HA-DOTATATE Accumulation in Salvage Meningioma Patients
        You have access
        Intraarterial Administration Boosts 177Lu-HA-DOTATATE Accumulation in Salvage Meningioma Patients
        Evert-Jan P.A. Vonken, Rutger C.G. Bruijnen, Tom J. Snijders, Tatjana Seute, Marnix G.E.H. Lam, Bart de Keizer and Arthur J.A.T. Braat
        Journal of Nuclear Medicine March 1, 2022, 63 (3) 406-409; DOI: https://doi.org/10.2967/jnumed.121.262491
    • BRIEF COMMUNICATION

      • <sup>177</sup>Lu-Prostate-Specific Membrane Antigen Ligand After <sup>223</sup>Ra Treatment in Men with Bone-Metastatic Castration-Resistant Prostate Cancer: Real-World Clinical Experience
        Open Access
        177Lu-Prostate-Specific Membrane Antigen Ligand After 223Ra Treatment in Men with Bone-Metastatic Castration-Resistant Prostate Cancer: Real-World Clinical Experience
        Oliver Sartor, Christian la Fougère, Markus Essler, Samer Ezziddin, Gero Kramer, Jörg Ellinger, Luke Nordquist, John Sylvester, Giovanni Paganelli, Avivit Peer, Martin Bögemann, Jeffrey Meltzer, Per Sandström, Frank Verholen and Daniel Y. Song
        Journal of Nuclear Medicine March 1, 2022, 63 (3) 410-414; DOI: https://doi.org/10.2967/jnumed.121.262240
    • FEATURED ARTICLE OF THE MONTH

      • Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using <sup>177</sup>Lu-FAP-2286: First-in-Humans Results
        Open Access
        Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using 177Lu-FAP-2286: First-in-Humans Results
        Richard P. Baum, Christiane Schuchardt, Aviral Singh, Maythinee Chantadisai, Franz C. Robiller, Jingjing Zhang, Dirk Mueller, Alexander Eismant, Frankis Almaguel, Dirk Zboralski, Frank Osterkamp, Aileen Hoehne, Ulrich Reineke, Christiane Smerling and Harshad R. Kulkarni
        Journal of Nuclear Medicine March 1, 2022, 63 (3) 415-423; DOI: https://doi.org/10.2967/jnumed.120.259192
  • Basic

    • A Radiotracer for Molecular Imaging and Therapy of Gastrin-Releasing Peptide Receptor–Positive Prostate Cancer
      You have access
      A Radiotracer for Molecular Imaging and Therapy of Gastrin-Releasing Peptide Receptor–Positive Prostate Cancer
      Ivica J. Bratanovic, Chengcheng Zhang, Zhengxing Zhang, Hsiou‐Ting Kuo, Nadine Colpo, Jutta Zeisler, Helen Merkens, Carlos Uribe, Kuo‐Shyan Lin and François Bénard
      Journal of Nuclear Medicine March 1, 2022, 63 (3) 424-430; DOI: https://doi.org/10.2967/jnumed.120.257758

Cardiovascular

  • Clinical

    • Sex Differences and Caffeine Impact in Adenosine-Induced Hyperemia
      Open Access
      Sex Differences and Caffeine Impact in Adenosine-Induced Hyperemia
      Martin Lyngby Lassen, Christina Byrne, Majid Sheykhzade, Mads Wissenberg, Preetee Kapisha Hurry, Anne Vibeke Schmedes, Andreas Kjaer and Philip Hasbak
      Journal of Nuclear Medicine March 1, 2022, 63 (3) 431-437; DOI: https://doi.org/10.2967/jnumed.121.261970

Neurology

  • Clinical

    • Striatal Acetylcholine–Dopamine Imbalance in Parkinson Disease: In Vivo Neuroimaging Study with Dual-Tracer PET and Dopaminergic PET–Informed Correlational Tractography
      You have access
      Striatal Acetylcholine–Dopamine Imbalance in Parkinson Disease: In Vivo Neuroimaging Study with Dual-Tracer PET and Dopaminergic PET–Informed Correlational Tractography
      Carlos A. Sanchez-Catasus, Nicolaas I. Bohnen, Nicholas D’Cruz and Martijn L.T.M. Müller
      Journal of Nuclear Medicine March 1, 2022, 63 (3) 438-445; DOI: https://doi.org/10.2967/jnumed.121.261939
  • Basic

    • FEATURED BASIC SCIENCE ARTICLE

      • A Longitudinal PET/MRI Study of Colony-Stimulating Factor 1 Receptor–Mediated Microglia Depletion in Experimental Stroke
        Open Access
        A Longitudinal PET/MRI Study of Colony-Stimulating Factor 1 Receptor–Mediated Microglia Depletion in Experimental Stroke
        Cristina Barca, Amanda J. Kiliaan, Claudia Foray, Lydia Wachsmuth, Sven Hermann, Cornelius Faber, Michael Schäfers, Maximilian Wiesmann, Andreas H. Jacobs and Bastian Zinnhardt
        Journal of Nuclear Medicine March 1, 2022, 63 (3) 446-452; DOI: https://doi.org/10.2967/jnumed.121.262279

Infectious Disease

  • Clinical

    • Lessons Learned from Post–COVID-19 Vaccination PET/CT Studies
      Open Access
      Lessons Learned from Post–COVID-19 Vaccination PET/CT Studies
      Marina Orevi, Alexandre Chicheportiche and Simona Ben Haim
      Journal of Nuclear Medicine March 1, 2022, 63 (3) 453-460; DOI: https://doi.org/10.2967/jnumed.121.262348

Molecular Imaging

  • Basic

    • PET Tracing of Biodistribution for Orally Administered <sup>64</sup>Cu-Labeled Polystyrene in Mice
      Open Access
      PET Tracing of Biodistribution for Orally Administered 64Cu-Labeled Polystyrene in Mice
      Changkeun Im, Hyeongi Kim, Javeria Zaheer, Jung Young Kim, Yong-Jin Lee, Choong Mo Kang and Jin Su Kim
      Journal of Nuclear Medicine March 1, 2022, 63 (3) 461-467; DOI: https://doi.org/10.2967/jnumed.120.256982

AI/Advanced Image Analysis

  • Clinical

    • Evaluation of Deep Learning–Based Approaches to Segment Bowel Air Pockets and Generate Pelvic Attenuation Maps from CAIPIRINHA-Accelerated Dixon MR Images
      You have access
      Evaluation of Deep Learning–Based Approaches to Segment Bowel Air Pockets and Generate Pelvic Attenuation Maps from CAIPIRINHA-Accelerated Dixon MR Images
      Hasan Sari, Ja Reaungamornrat, Onofrio A. Catalano, Javier Vera-Olmos, David Izquierdo-Garcia, Manuel A. Morales, Angel Torrado-Carvajal, Thomas S.C. Ng, Norberto Malpica, Ali Kamen and Ciprian Catana
      Journal of Nuclear Medicine March 1, 2022, 63 (3) 468-475; DOI: https://doi.org/10.2967/jnumed.120.261032

Physics and Instrumentation

  • Basic

    • Performance Characteristics of the Biograph Vision Quadra PET/CT System with a Long Axial Field of View Using the NEMA NU 2-2018 Standard
      You have access
      Performance Characteristics of the Biograph Vision Quadra PET/CT System with a Long Axial Field of View Using the NEMA NU 2-2018 Standard
      George A. Prenosil, Hasan Sari, Markus Fürstner, Ali Afshar-Oromieh, Kuangyu Shi, Axel Rominger and Michael Hentschel
      Journal of Nuclear Medicine March 1, 2022, 63 (3) 476-484; DOI: https://doi.org/10.2967/jnumed.121.261972

Special Contribution

  • You have access
    RADAR Guide: Standard Methods for Calculating Radiation Doses for Radiopharmaceuticals, Part 2—Data Analysis and Dosimetry
    Michael G. Stabin, Richard E. Wendt and Glenn D. Flux
    Journal of Nuclear Medicine March 1, 2022, 63 (3) 485-492; DOI: https://doi.org/10.2967/jnumed.121.262034

Letters To The Editor

  • You have access
    68Ga-NODAGA-Exendin-4 PET Scanning for Focal Congenital Hyperinsulinism: Need for Replication
    Indraneel Banerjee, Rakesh Sajjan, Maria Salomon Estebanez, Mark J. Dunne, Konrad Mohnike, Wolfgang Mohnike, Lisa J. States, Diva D. De Leon and Klaus Mohnike
    Journal of Nuclear Medicine March 1, 2022, 63 (3) 493; DOI: https://doi.org/10.2967/jnumed.121.262984
  • You have access
    Reply: 68Ga NODAGA-Exendin-4 PET Scanning for Focal Congenital Hyperinsulinism: Need for Replication
    Vikas Prasad, Marti Boss, Christof Rottenburger, Winfried Brenner, Oliver Blankenstein, Sonal Prasad, Mijke Buitinga, Pratik Shah and Martin Gotthardt
    Journal of Nuclear Medicine March 1, 2022, 63 (3) 493-494; DOI: https://doi.org/10.2967/jnumed.121.263167
  • You have access
    Adding Nontumor Radiomic Features to the Prognostic Model Is Bothersome but Useful
    Lu Zhang and Bin Zhang
    Journal of Nuclear Medicine March 1, 2022, 63 (3) 494-495; DOI: https://doi.org/10.2967/jnumed.121.263479
  • You have access
    Reply: Adding Nontumor Radiomic Features to the Prognostic Model Is Bothersome but Useful
    Tahir I. Yusufaly and Loren K. Mell
    Journal of Nuclear Medicine March 1, 2022, 63 (3) 495; DOI: https://doi.org/10.2967/jnumed.121.263730

SNMMI Newsline

  • You have access
    SNMMI Newsline
    Journal of Nuclear Medicine March 1, 2022, 63 (3) 11N-22N;
  • You have access
    SNMMI Statement: Possible Effect of Omicron Infection on 18F-FDG–Based Imaging
    Journal of Nuclear Medicine March 1, 2022, 63 (3) 11N;
  • You have access
    CMS Proposes Medicare Coverage Policy for Monoclonal Antibody–Based Alzheimer Treatment
    Journal of Nuclear Medicine March 1, 2022, 63 (3) 12N;
  • You have access
    SNMMI Reacts to CMS Coverage Decision
    Journal of Nuclear Medicine March 1, 2022, 63 (3) 12N;
  • You have access
    HFR Outage and Isotope Supply
    Journal of Nuclear Medicine March 1, 2022, 63 (3) 13N;
  • You have access
    FDA Guidance on Patient Engagement in Medical Device Clinical Studies
    Journal of Nuclear Medicine March 1, 2022, 63 (3) 13N;
  • You have access
    SNMMI Launches Radiopharmaceutical Therapy Centers of Excellence Program
    Journal of Nuclear Medicine March 1, 2022, 63 (3) 14N;
  • You have access
    SNMMI Leadership Update: Call the Nuclear Oncologist
    Richard L. Wahl
    Journal of Nuclear Medicine March 1, 2022, 63 (3) 15N;
  • You have access
    Newsbriefs
    Journal of Nuclear Medicine March 1, 2022, 63 (3) 16N-17N;
  • You have access
    From the Literature
    Journal of Nuclear Medicine March 1, 2022, 63 (3) 18N-22N;
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 63 (3)
Journal of Nuclear Medicine
Vol. 63, Issue 3
March 1, 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)

Issue highlights

  • Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using 177Lu-FAP-2286: First-in-Humans Results
  • A Longitudinal PET/MRI Study of Colony-Stimulating Factor 1 Receptor–Mediated Microglia Depletion in Experimental Stroke
Sign up for alerts

Jump to

  • This Month in JNM
  • Discussions with Leaders
  • The State of The Art
  • Hot Topics
  • Continuing Education
  • Focus on Molecular Imaging
  • Oncology
    • Clinical
      • INVITED PERSPECTIVE
      • BRIEF COMMUNICATION
  • Theranostics
    • Clinical
      • BRIEF COMMUNICATION
      • BRIEF COMMUNICATION
      • BRIEF COMMUNICATION
      • FEATURED ARTICLE OF THE MONTH
    • Basic
  • Cardiovascular
    • Clinical
  • Neurology
    • Clinical
    • Basic
      • FEATURED BASIC SCIENCE ARTICLE
  • Infectious Disease
    • Clinical
  • Molecular Imaging
    • Basic
  • AI/Advanced Image Analysis
    • Clinical
  • Physics and Instrumentation
    • Basic
  • Special Contribution
  • Letters To The Editor
  • SNMMI Newsline
  • Most Cited
  • Most Read
Loading
  • Long-Term Follow-up and Outcomes of Retreatment in an Expanded 50-Patient Single-Center Phase II Prospective Trial of 177Lu-PSMA-617 Theranostics in Metastatic Castration-Resistant Prostate Cancer
  • First-in-Human Assessment of 11C-LSN3172176, an M1 Muscarinic Acetylcholine Receptor PET Radiotracer
  • Impact of 68Ga-PSMA-11 PET/CT on Staging and Management of Prostate Cancer Patients in Various Clinical Settings: A Prospective Single-Center Study
  • Tau PET imaging with 18F-PI-2620 in Patients with Alzheimer Disease and Healthy Controls: A First-in-Humans Study
  • Radiation Dosimetry in 177Lu-PSMA-617 Therapy Using a Single Posttreatment SPECT/CT Scan: A Novel Methodology to Generate Time- and Tissue-Specific Dose Factors
More...
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire